Alzheimer's disease: clinical trials and drug development.
about
Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disordersLatrepirdine for Alzheimer's diseaseDimebon for Alzheimer's diseaseBrain investigation and brain conceptualizationTHE ROLE OF CYSTEINE PROTEASE IN ALZHEIMER DISEASEMultiple Targeting Approaches on Histamine H3 Receptor AntagonistsThe ubiquitin proteasomal system: a potential target for the management of Alzheimer's diseaseModulation of neurotrophic signaling pathways by polyphenolsTransient dynamics of Aβ contribute to toxicity in Alzheimer's diseaseHuman fetal tau protein isoform: possibilities for Alzheimer's disease treatmentCombotherapy and current concepts as well as future strategies for the treatment of Alzheimer's diseaseCommon defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploringRodent models of neuroinflammation for Alzheimer's diseaseNew pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsNetwork dysfunction in Alzheimer's disease: refining the disconnection hypothesisDisrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal modelsClinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersEpigenetics of Alzheimer's disease and frontotemporal dementiaAdipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseasesNeuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapyMild cognitive impairment: diagnosis, longitudinal course, and emerging treatmentsAlzheimer's-related peptide amyloid-β plays a conserved role in angiogenesisDifferential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic markerNeuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylationThe Government's role in regulating, coordinating, and standardizing the response to Alzheimer's disease: Anticipated international cooperation in the area of intractable and rare diseasesEpigenetic Changes in Neurodegenerative DiseasesAnti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's diseaseModulators of γ-secretase activity can facilitate the toxic side-effects and pathogenesis of Alzheimer's diseaseDevelopment and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer's diseaseMagnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's modelUncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD NetworkDementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South AmericaNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialEpidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss.The effect of PN-1, a Traditional Chinese Prescription, on the Learning and Memory in a Transgenic Mouse Model of Alzheimer's Disease.NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy.Transcriptional data: a new gateway to drug repositioning?Current neuroimaging techniques in Alzheimer's disease and applications in animal modelsA novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice
P2860
Q21146612-79F27A19-5930-484A-BDB1-C4DF34F25F35Q24186444-87C05F4D-DBE2-41C7-8D08-CF45754B6795Q24234998-976F4F2A-91FB-48F7-A471-320120E56C0BQ24604341-0A4655D5-507A-4F99-8E19-B155A05880AAQ26740104-77321A44-1A01-4B73-9B39-D9B4C4265C5FQ26746056-F5EC732F-B881-4F4C-BB54-203EB47D5B06Q26749321-4C7E8F73-2D61-46E1-9B9E-FDAB2181FA70Q26771195-67496F5D-D4E5-49FB-B782-DDA975FDBFACQ26827421-F07DFC2B-72CC-4BC5-BDAF-651A6984D71EQ26829893-B6DAF8A1-11C4-4B66-B2FB-11932998A1CBQ26829899-6B18F874-701B-4A9E-8F00-231D52A3166EQ26861082-500F6D95-70A8-4C09-A8E8-DED78ABC86CCQ26864804-0ECF297B-0DBC-4C69-AFB3-D39A9B502D25Q26866006-92B6282B-D51E-4392-A53E-F6178CDD4983Q26995432-25671604-F7F3-4A93-AC2E-1E2A113FADAFQ26995918-B459A282-6F95-49D4-8377-DF47552F1032Q27008249-9D8B2DC1-E69A-497B-89B3-175777CA4E2DQ27010153-DA88D865-7A99-4CF0-BD3E-11A10D21C3B4Q27011815-3638B268-B5B1-4182-A9BF-76DF13CAD63FQ27014919-513DB934-6659-4A97-9B54-0AC9D9261678Q27026362-7353BA87-64F9-4C0E-954E-4C55AB6F581AQ27300765-F2BBC42D-68EE-4AF5-9B83-2E92766542A0Q27339637-ED0E9D94-B723-4EDC-A70D-1E22C0D62204Q27499804-A60CA0AB-66A7-402C-B3C3-C929E44CAA2AQ28072842-754B5B44-0DFA-44CB-BE6F-E351101EC08BQ28075559-3D01EF13-4DA4-408C-93DC-8115ED10DB84Q28477320-391259C4-7986-4F2E-8540-2E3FAD74DC9DQ28484883-6CAF6573-271F-4DD7-8230-8FE4A7D1CF5BQ28535175-9AE4BCA8-CAB5-46EA-BE83-4FF24DD4289FQ28543427-04743B19-0D8D-428E-97FA-25FC080361A4Q28551442-6ECDFED1-E678-4689-B00B-D71590C0458AQ28817091-B7FD1D85-2974-412B-87FD-BF13FEE8C9F6Q29615839-CECCED5A-364B-4925-83C6-F140744192F6Q29994589-73654826-30ED-4978-A8FF-649F410BD02BQ30420041-42A3C341-2F5B-412A-9A8D-E8C58F9AE113Q30537187-1F565D36-DB63-48A5-A645-FC89032C04DDQ30540857-2A66848B-BB1B-49E2-847A-912AF8EBBAEFQ30557854-0D3AD600-AE92-4971-BF6A-F333FF68ECDBQ30576714-FAA425CE-7A59-4A7A-9A94-C02534EDA69DQ30579707-87121AB5-074E-42FD-993F-D56C7FE788A8
P2860
Alzheimer's disease: clinical trials and drug development.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Alzheimer's disease: clinical trials and drug development.
@ast
Alzheimer's disease: clinical trials and drug development.
@en
type
label
Alzheimer's disease: clinical trials and drug development.
@ast
Alzheimer's disease: clinical trials and drug development.
@en
prefLabel
Alzheimer's disease: clinical trials and drug development.
@ast
Alzheimer's disease: clinical trials and drug development.
@en
P50
P1433
P1476
Alzheimer's disease: clinical trials and drug development.
@en
P2093
Alina Solomon
Francesca Mangialasche
P304
P356
10.1016/S1474-4422(10)70119-8
P407
P577
2010-07-01T00:00:00Z